Impact of antimicrobial stewardship in organisms causing nosocomial infection among COVID-19 critically ill adults

Since the firsts reports of a novel viral respiratory illness emerged in December 2019 in Hubei province, China [1], the severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) has infected millions worldwide and is responsible for more than six million deaths [2].